Regeneron Pharmaceuticals

Market Cap (Mar-08-2026)

80.332 Billion USD

World Rank (Jan-05-2024)

144

Market Cap (Jan-05-2024)

100.011 Billion USD

World Rank (Jul-30-2023)

174

Market Cap (Jul-30-2023)

81.855 Billion USD

World Rank (Jan-07-2022)

279

Market Cap (Jan-07-2022)

64.927 Billion USD

World Rank (Jan-01-2021)

308

Market Cap (Jan-01-2021)

51.551 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 97

Headquarters Country

USA

Nasdaq / NYSE Code

REGN

CEO

Leonard Schleifer

Founders

Leonard Schleifer

Eric Manvers Shooter

Employee Count

11,851

Employee Count as of Date

As on Dec-2022

Headquarters City/State

New York

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

14,343 Million USD

Annual Operating Income in USD

3,578 Million USD

Annual Net Income in USD

4,505 Million USD

Annual Results for Period Ending

Dec-2025 ending year

Total Assets in USD

40,559 Million USD

Total Liabilities in USD

9,302 Million USD

Total Equity in USD

31,257 Million USD

Balance Sheet for Period Ending

Dec-2025 ending year

Business Sector

Company Website

REGENERON PHARMACEUTICALS INC

Wikipedia

Yahoo

Yahoo @ Nasdaq

Facebook

Company Profile

REGENERON PHARMACEUTICALS is Bio-Pharmaceutical company with headquarters is in New York, USA.

As on 2022, REGENERON PHARMACEUTICALS has 11,851 employees.

Facts About Company

REGENERON PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 12,172 million USD.

REGENERON PHARMACEUTICALS annual net income generated for period ending Dec-2022 was 4,338 million USD.

As on 2022, they had 11,851 employees. They had 7 FDA approved medicines.

Annual Results Summary

REGENERON PHARMACEUTICALS - Annual Results Summary - in Million USD :

Year	Total Annual Revenue ($mm)	Gross Profit ($mm)	Operating Profit ($mm)	Net Income ($mm)
2025	14,342.9	12,242.2	3,577.9	4,504.9
2024	14,202.0	12,231.5	3,990.7	4,412.6
2023	13,117.2	11,301.4	4,047.1	3,953.6
2022	12,172.9	10,612.5	4,738.9	4,338.4
2021	16,071.7	13,634.2	8,946.8	8,075.3
2020	8,497.1	7,377.2	3,576.6	3,513.2
2019	7,863.4	7,081.2	2,209.8	2,115.8
2018	6,710.8	6,276.7	2,534.4	2,444.4
2017	5,872.2	5,475.1	2,079.6	1,198.5
2016	4,860.4	4,560.7	1,330.7	895.5

Balance Sheet Summary

REGENERON PHARMACEUTICALS - Balance Sheet Summary - in Million USD :

Year	Total Assets ($mm)	Total Liabilities ($mm)	Total Equity ($mm)
2025	40,558.7	9,301.8	31,256.9
2024	37,759.4	8,405.8	29,353.6
2023	33,080.2	7,107.1	25,973.1
2022	29,214.5	6,550.5	22,664.0
2021	25,434.8	6,666.0	18,768.8
2020	17,163.3	6,138.0	11,025.3
2019	14,805.2	3,715.5	11,089.7
2018	11,734.5	2,977.2	8,757.3
2017	8,764.286	2,620.208	6,144.078
2016	6,973.466	2,524.221	4,449.245

Founded Year

1988

Institutional Investors

Top 30 Institutional Holder Names in REGENERON PHARMACEUTICALS as on SEP-30-2023

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	FMR LLC	09/30/2023	98,40,892	6,69,517	7.30%	$7,797,726
2	BLACKROCK INC.	09/30/2023	88,75,309	-2,10,673	-2.32%	$7,032,617
3	VANGUARD GROUP INC	09/30/2023	87,98,505	-58,533	-0.66%	$6,971,759
4	JPMORGAN CHASE & CO	09/30/2023	73,89,154	8,45,167	12.92%	$5,855,018
5	CAPITAL WORLD INVESTORS	09/30/2023	51,07,339	-4,43,043	-7.98%	$4,046,953
6	STATE STREET CORP	09/30/2023	48,29,106	-1,61,764	-3.24%	$3,826,487
7	CAPITAL INTERNATIONAL INVESTORS	09/30/2023	29,74,338	17,723	0.60%	$2,356,806
8	DODGE & COX	09/30/2023	23,72,998	-21,357	-0.89%	$1,880,316
9	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	23,19,986	38,857	1.70%	$1,838,311
10	PRICE T ROWE ASSOCIATES INC /MD/	09/30/2023	22,17,665	-34,598	-1.54%	$1,757,233
11	WELLINGTON MANAGEMENT GROUP LLP	09/30/2023	15,06,885	-1,62,047	-9.71%	$1,194,026
12	WESTWOOD HOLDINGS GROUP INC	12/31/2022	14,97,842	14,80,215	8397.43%	$1,186,860
13	LOOMIS SAYLES & CO L P	09/30/2023	12,32,879	-44,605	-3.49%	$976,909
14	PUTNAM INVESTMENTS LLC	09/30/2023	11,86,406	17,085	1.46%	$940,084
15	NORTHERN TRUST CORP	09/30/2023	10,67,210	34,326	3.32%	$845,636
16	MORGAN STANLEY	09/30/2023	9,70,957	25,792	2.73%	$769,367
17	BANK OF NEW YORK MELLON CORP	09/30/2023	9,67,414	2,666	0.28%	$766,560
18	NORGES BANK	12/31/2022	9,66,467	59,854	6.60%	$765,809
19	AMERICAN CENTURY COMPANIES INC	09/30/2023	9,16,718	30,050	3.39%	$726,389
20	BANK OF AMERICA CORP /DE/	09/30/2023	8,36,859	-1,686	-0.20%	$663,110
21	LEGAL & GENERAL GROUP PLC	09/30/2023	8,20,208	-26,921	-3.18%	$649,916
22	INVESCO LTD.	09/30/2023	7,43,348	-1,65,714	-18.23%	$589,014
23	NEUBERGER BERMAN GROUP LLC	09/30/2023	7,07,811	-852	-0.12%	$560,855
24	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	6,95,387	29,203	4.38%	$551,011
25	ALLIANCEBERNSTEIN L.P.	09/30/2023	6,92,258	4,399	0.64%	$548,531
26	AMUNDI	09/30/2023	6,85,286	574	0.08%	$543,007
27	DIMENSIONAL FUND ADVISORS LP	09/30/2023	6,19,266	6,442	1.05%	$490,694
28	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	5,98,058	-1,978	-0.33%	$473,889
29	EP WEALTH ADVISORS, LLC	06/30/2023	5,69,130	-39,80,870	-87.49%	$450,967
30	FRANKLIN RESOURCES INC	09/30/2023	4,83,210	-5,454	-1.12%	$382,886